Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma

✍ Scribed by Nicolaus Kröger; Bronwen Shaw; Simona Iacobelli; Tatjana Zabelina; Karl Peggs; Avichai Shimoni; Arnon Nagler; Thomas Binder; Thomas Eiermann; Alejandro Madrigal; Rainer Schwerdtfeger; Michael Kiehl; Herbert Gottfried Sayer; Jörg Beyer; Martin Bornhäuser; Francis Ayuk; Axel Rolf Zander; David I. Marks; the Clinical Trial Committee of the British Society of Blood; Marrow Transplantation; the German Cooperative Transplant Group

• Book ID: 108673201
• Publisher: John Wiley and Sons
• Year: 2005
• Tongue: English
• Weight: 171 KB
• Volume: 129
• Category: Article
• ISSN: 0007-1048
• DOI: 10.1111/j.1365-2141.2005.05513.x